Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Diet can influence inflammatory skin diseases.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Accurate diagnosis of APL is crucial to avoid unnecessary treatments.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

Finasteride can cause recurrent mouth ulcers.

Iron deficiency worsens inflammatory skin diseases by disrupting iron balance and increasing inflammation.

Artefactual skin disorder involves self-inflicted skin lesions linked to mental health issues, needing combined medical and psychological treatment.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

An adult woman with scalp infection recovered after antifungal treatment, with no return of symptoms.

Microneedle patches improve drug delivery for skin treatments and cosmetic enhancements.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

PPAR-γ agonists like pioglitazone may help manage lichen planopilaris but don't fully reverse scarring.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Proper nutrition is crucial for managing pediatric inflammatory bowel disease and supporting growth and development.

Improving human hair follicle models is crucial for better hair loss treatments.

Human placenta hydrolysate reduces inflammatory pain and nerve damage in mice.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

A woman with lupus and severe nerve damage improved with specific treatments.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Combining PRP and MSCs improves skin healing and structure.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.